Supplementary Figure S1 from A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents

Antoine Azan, Peter J. Caspers, Tom C. Bakker Schut,Séverine Roy,Céline Boutros,Christine Mateus,Emilie Routier,Benjamin Besse, David Planchard, Atmane Seck, Nyam Kamsu Kom, Gorana Tomasic, Senada Koljenović,Vincent Noordhoek Hegt,Matthieu Texier, Emilie Lanoy, Alexander M.M. Eggermont, Angelo Paci,Caroline Robert,Gerwin J. Puppels,Lluis M. Mir

openalex（2023）

引用 0|浏览1

暂无评分

摘要

Mean LD score for the validation data set for Stratum Corneum skin layer for MEK inhibitors (A), EGFR inhibitors (B) and BRAF inhibitors (C) and for Viable Epidermis skin layer for MEK inhibitors (D), EGFR inhibitors (E) and BRAF inhibitors (F). The p-value between the two groups is reported. In the 6 conditions, the p-value is lower than 0.001%.

查看译文

关键词

MEK Inhibition,Vascular Targeting Agents

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要